Shuttle Pharmaceuticals【SHPH】株式ニュース

名称	銘柄コード	市場	種別
Shuttle Pharmaceuticals Holdings Inc	SHPH	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.0297	7.82%	0.409699	23:07:55

始値	安値	高値	終値	前日終値
0.3784	0.3784	0.4097		0.38

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/18	22:00	EDGAR2	Form 8-K - Current report
2024/6/18	22:00	GLOBE	Shuttle Pharma Appoints Timothy Lorber as Chief Financial..
2024/6/10	19:12	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2024/5/23	05:15	EDGAR2	Form 8-K - Current report
2024/5/23	05:15	GLOBE	Shuttle Pharma to Participate in the Lytham Partners Spring..
2024/5/14	22:00	EDGAR2	Form 8-K - Current report
2024/5/14	22:00	GLOBE	Shuttle Pharma Provides First Quarter 2024 Corporate Update
2024/5/14	06:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/4/24	05:15	GLOBE	Shuttle Pharmaceuticals to Present at the Planet MicroCap..
2024/3/22	22:00	PRNUS	Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
2024/3/09	08:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	23:00	EDGAR2	Form 8-K - Current report
2024/2/13	22:00	EDGAR2	Form 8-K - Current report
2024/2/13	22:00	PRNUS	Shuttle Pharma Announces Its Intent to Pursue a Rights..
2024/2/06	06:25	EDGAR2	Form 8-K - Current report
2024/1/24	06:30	PRNUS	Shuttle Pharma to Participate in a Fireside Chat at the..
2024/1/08	23:05	EDGAR2	Form 8-K - Current report
2024/1/08	23:00	PRNUS	Shuttle Pharmaceuticals Receives FDA Approval to Proceed..
2024/1/03	07:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	11:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/20	07:10	EDGAR2	Form 8-K - Current report
2023/12/11	23:00	EDGAR2	Form 8-K - Current report
2023/12/11	23:00	PRNUS	Shuttle Pharmaceuticals Submits IND Application to the U.S...
2023/11/30	23:00	EDGAR2	Form 8-K - Current report
2023/11/14	23:00	PRNUS	Shuttle Pharmaceuticals Provides Third Quarter 2023..
2023/11/14	06:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31	22:00	PRNUS	Shuttle Pharma Advances Prostate Cancer Predictive Biomarker..
2023/10/31	06:14	EDGAR2	Form 8-K - Current report
2023/10/21	05:15	EDGAR2	Form ARS - Annual Report to Security Holders
2023/10/21	05:10	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/10/10	22:00	EDGAR2	Form 8-K - Current report
2023/10/10	22:00	PRNUS	Shuttle Pharma to Participate in the Lytham Partners Fall..
2023/10/06	05:10	EDGAR2	Form 8-K - Current report
2023/9/25	22:00	EDGAR2	Form 8-K - Current report
2023/9/25	22:00	PRNUS	Shuttle Pharma Announces Results of Pre-IND Meeting with FDA..
2023/9/13	22:00	PRNUS	Shuttle Pharma Participates in Hampton University Proton..
2023/9/11	22:00	PRNUS	Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor..
2023/9/07	22:20	EDGAR2	Form 8-K - Current report
2023/8/29	22:00	PRNUS	Shuttle Pharma's Selective HDAC6 Inhibitor Shown to..
2023/8/25	03:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/19	08:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	22:00	EDGAR2	Form 8-K - Current report
2023/8/15	22:00	PRNUS	Shuttle Pharmaceuticals Provides Second Quarter 2023..
2023/8/15	05:14	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/03	22:00	EDGAR2	Form 8-K - Current report
2023/8/03	22:00	PRNUS	Shuttle Pharmaceuticals Completes Manufacturing of Active..